Related Experiment Video
Updated: Mar 9, 2026

10:46
Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
11.8K
Paroxysmal Nonepileptic Events in Glut1 Deficiency
Joerg Klepper1, Baerbel Leiendecker2, Christin Eltze3
1Department of Pediatrics and Neuropediatrics Children's Hospital Aschaffenburg-Alzenau Aschaffenburg Germany.
Movement Disorders Clinical Practice
|January 3, 2017
Summary
Paroxysmal movement disorders are a key feature of Glut1 deficiency syndrome in children. These events, triggered by exercise and low ketosis, link pediatric and adult manifestations.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Glut1 deficiency syndrome (Glut1DS) is a rare metabolic disorder affecting glucose transport into the brain.
- Movement disorders are a hallmark clinical manifestation of Glut1DS.
- Paroxysmal exercise-induced dystonia has been identified in adults with Glut1DS.
Observation:
- This case series investigated paroxysmal events in pediatric Glut1DS patients.
- Parent-recorded videos and questionnaires were utilized to document clinical presentations.
- Three children's videos depicted ataxic-dystonic, choreatiform, and dyskinetic-dystonic features during events.
Findings:
- Fifty-six questionnaires confirmed paroxysmal events in 73% of pediatric patients.
- These events increased with age and were triggered by low ketosis, sleep deprivation, and exercise.
- No correlation was found with sex, hypoglycorrhachia, SLC2A1 mutations, or ketogenic diet type.
Implications:
- Paroxysmal events are a significant clinical feature in pediatric Glut1DS.
- This finding establishes a clinical link between pediatric Glut1DS and adult-onset exercise-induced paroxysmal dyskinesias.
- Understanding these triggers can inform clinical management and patient counseling for Glut1DS.
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Inborn Errors of Metabolism
967
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
967
Glucose Transporters
27.9K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.9K
Antiepileptic Drugs: Potassium Channel Activators
880
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
880
Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Protein Import into the Peroxisomes
5.6K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.6K

